Medicaid to begin covering CareDx's AlloSure

The Centers for Medicare and Medicaid Services will begin covering CareDx Inc.'s (Nasdaq: CDNA) AlloSure beginning on October 9, 2017. Shares of the molecular diagnostics company climbed 71 cents to close at $2.86.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.